Bayer
This article was originally published in The Tan Sheet
Executive Summary
Consumer Care operations would be unaffected by sell-off of pharma business, German firm says. Company is considering options for Rx segment following withdrawal of Rx cholesterol-lowering statin Baycol due to adverse effects (1"The Tan Sheet" Aug. 13, In Brief). Baycol problems also postpone NYSE listing from Sept. 26 to early February